Biotech Vertex, known for its cystic fibrosis therapies, is set to report earnings on Feb. 12 ...
Krystal Biotech received FDA RMAT designation for inhaled KB707 in advanced NSCLC, based on a 36% ORR in heavily pretreated ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results